Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Investors Business Daily
Investors Business Daily
Business
INVESTOR'S BUSINESS DAILY

Archrock Gets IBD Stock Rating Upgrade

On Wednesday, Archrock got an upgrade for its IBD SmartSelect Composite Rating from 93 to 96.

The new rating shows the stock is outpacing 96% of all stocks when it comes to the most important stock-picking criteria.

Archrock is now out of buy range after clearing the 21.87 entry in a cup with handle.

Looking For Winning Stocks? How To Invest In Both Bull And Bear Markets

The stock has a 99 EPS Rating, which means its recent quarterly and longer-term annual earnings growth is outpacing 99% of all stocks.

Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.

In Q3, the company posted 40% earnings growth. Revenue growth climbed 15%, up from 9% in the prior quarter. That marks one quarter of increasing revenue growth.

Archrock holds the No. 2 rank among its peers in the Oil & Gas-Machinery/Equipment industry group. Chart Industries is the No. 1-ranked stock within the group.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.